✦ LIBER ✦

Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization

✍ Scribed by A D Graham; D Faratian; F Rae; J St J Thomas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tissue microarray technology in the rout

✍ Jane Cryan; Anthony O’Grady; David Allen; Elaine Kay 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

Comparing Fluorescence In Situ Hybridiza

✍ Park, K. 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 926 KB

HER2 status in pure ductal carcinoma in

✍ K Park; S Han; H J Kim; J Kim; E Shin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Reliability of chromogenic in situ hybri

✍ Gong, Yun; Gilcrease, Michael; Sneige, Nour 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 230 KB

Chromogenic in situ hybridization for He

✍ Doris Mayr; Sibylle Heim; Kerstin Weyrauch; Evelyn Zeindl-Eberhart; Anne Kunz; J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

Confrontation of immunohistochemistry an

✍ Gonzague de Pinieux; Delphine Colin; Anne Vincent-Salomon; Jérôme Couturier; Del 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 279 KB